
News|Slideshows|September 26, 2024
7 Drugs Approved for Primary Care: Q3 2024
Author(s)Sydney Jennings
Updated mRNA COVID-19 vaccines, the first orally disintegrating tablet approved for pregnancy prevention, and 5 more.
Advertisement
As another quarter rounds out, a new batch of drugs have been approved by the US FDA for conditions often seen in primary care. Below, find details on the updated 2024-2025 formulations of mRNA COVID-19 vaccines, the first and only needle-free treatment alternative to epinephrine injection, the first orally disintegrating tablet to receive FDA approval for pregnancy prevention, and 4 more.
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Patient Care Online
1
Icotrokinra Outperforms Advanced Oral Psoriasis Treatments, Matches IL-23 Injectables in Achieving Complete Skin Clearance: Maui Derm 2026
2
Topline Phase 2 Data Show Roflumilast Cream Improves Atopic Dermatitis in Infants as Young as 3 Months
3
FDA Issues Complete Response Letter to Dibutepinephrine (Anaphylm) Sublingual Film for Anaphylaxis
4
Primary Care Physician Kevin Hatfield, MD, on Barriers to Daily Oral PrEP Adherence
5

































































































































